The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement
LA Lewis, J Ngampasutadol, R Wallace… - PLoS …, 2010 - journals.plos.org
Complement forms an important arm of innate immunity against invasive meningococcal
infections. Binding of the alternative complement pathway inhibitor factor H (fH) to fH-binding …
infections. Binding of the alternative complement pathway inhibitor factor H (fH) to fH-binding …
Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce …
KL Seib, B Brunelli, B Brogioni, E Palumbo… - Infection and …, 2011 - Am Soc Microbiol
Neisseria meningitidis is a commensal of the human nasopharynx but is also a major cause
of septicemia and meningitis. The meningococcal factor H binding protein (fHbp) binds …
of septicemia and meningitis. The meningococcal factor H binding protein (fHbp) binds …
Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease
LK McNeil, RJ Zagursky, SL Lin, E Murphy… - Microbiology and …, 2013 - Am Soc Microbiol
Neisseria meningitidis is a Gram-negative microorganism that exists exclusively in humans
and can cause devastating invasive disease. Although capsular polysaccharide-based …
and can cause devastating invasive disease. Although capsular polysaccharide-based …
Binding of complement factor H to PorB3 and NspA enhances resistance of Neisseria meningitidis to anti-factor H binding protein bactericidal activity
S Giuntini, R Pajon, S Ram, DM Granoff - Infection and immunity, 2015 - Am Soc Microbiol
Among 25 serogroup B Neisseria meningitidis clinical isolates, we identified four (16%) with
high factor H binding protein (FHbp) expression that were resistant to complement-mediated …
high factor H binding protein (FHbp) expression that were resistant to complement-mediated …
The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance
G Madico, JA Welsch, LA Lewis… - The Journal of …, 2006 - journals.aai.org
Neisseria meningitidis binds factor H (fH), a key regulator of the alternative complement
pathway. A∼ 29 kD fH-binding protein expressed in the meningococcal outer membrane …
pathway. A∼ 29 kD fH-binding protein expressed in the meningococcal outer membrane …
Distinct binding and immunogenic properties of the gonococcal homologue of meningococcal factor h binding protein
I Jongerius, H Lavender, L Tan, N Ruivo… - PLoS …, 2013 - journals.plos.org
Neisseria meningitidis is a leading cause of sepsis and meningitis. The bacterium recruits
factor H (fH), a negative regulator of the complement system, to its surface via fH binding …
factor H (fH), a negative regulator of the complement system, to its surface via fH binding …
Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein
J Lucidarme, L Tan, RM Exley, J Findlow… - Clinical and Vaccine …, 2011 - Am Soc Microbiol
Neisseria meningitidis remains a leading cause of bacterial sepsis and meningitis.
Complement is a key component of natural immunity against this important human …
Complement is a key component of natural immunity against this important human …
Complement-dependent synergistic bactericidal activity of antibodies against factor H–binding protein, a sparsely distributed meningococcal vaccine antigen
JA Welsch, S Ram, O Koeberling… - The Journal of …, 2008 - academic.oup.com
Background Antibodies to factor H (fH)–binding protein (fHBP), a meningococcal vaccine
antigen, activate classical complement pathway serum bactericidal activity (SBA) and block …
antigen, activate classical complement pathway serum bactericidal activity (SBA) and block …
Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen
KL Seib, M Scarselli, M Comanducci… - Expert review of …, 2015 - Taylor & Francis
Neisseria meningitidis is a leading cause of meningitis and sepsis worldwide. The first broad-
spectrum multicomponent vaccine against serogroup B meningococcus (MenB), 4CMenB …
spectrum multicomponent vaccine against serogroup B meningococcus (MenB), 4CMenB …
Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules
Neisseria meningitis remains a leading cause of sepsis and meningitis, and vaccines are
required to prevent infections by this important human pathogen. Factor H binding protein …
required to prevent infections by this important human pathogen. Factor H binding protein …
相关搜索
- meningococcal resistance surface protein
- meningococcal factor binding protein
- vaccine candidate meningococcal disease
- meningococcal factor serum resistance
- vaccine antigen binding protein
- meningococcal factor bactericidal antibodies
- vaccine antigen virulence factor
- meningococcal vaccines design and evaluation
- serum resistance binding protein
- protein factor serum resistance
- virulence factor binding protein